Effect of the Duration of Intraretinal or Subretinal Fluid on the Response to Treatment in Undertreated Age-Related Macular Degeneration

Table 1

Characteristics of subjects.

Eyes, N	80
Sex	Males: 57		Females: 15
Age	80.89 ± 6.49
Type	Classic: 6
	Occult: 20
	PCV: 36
	RAP: 4
	Cannot be classified or none fluorescein angiography: 14
Persistent SHRM (eyes)	74/80 (93%)
Photodynamic therapy (eyes)	Never: 59	Once: 14		Twice: 5	Three times: 2
Total number of injections (aflibercept or ranibizmab) (times)	Mean: 11.94 ± 6.43 (range, 0–28)
Total observation period (months)	Mean: 65.63 ± 29.77 (range, 10–144 months)
Injection span (months)	Mean: 9.28 ± 18.44 (range, 1.9–142)
Baseline logMAR VA	0.564 ± 0.456
Final logMAR VA	1.031 ± 0.381

Two eyes never had gone for injection.